An orally administered bifunctional gastrointestinal coating has been developed and shown to limit nutrient absorption through the bowel mucosa ultimately lowering blood glucose and also acting as a platform for delivery of drugs to the gastrointestinal tract.
References
Zheng, Y., Ley, S. H. & Hu, F. B. Nat. Rev. Endocrinol. 14, 88–98 (2017).
Lee, Y. et al. Nat. Mater. https://doi.org/10.1038/s41563-018-0106-5 (2018).
Schauer, P. R. et al. New Engl. J. Med. 376, 641–651 (2017).
Fuhrmann, K. & Fuhrmann, G. Curr. Opin. Colloid Interface Sci. 31, 67–74 (2017).
McCarville, J. L., Caminero, A. & Verdu, E. F. Curr. Opin. Pharmacol. 25, 7–12 (2015).
Fuhrmann, G. et al. Nat. Chem. 5, 582–589 (2013).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fuhrmann, G. Luminal coating of the intestine. Nature Mater 17, 754–755 (2018). https://doi.org/10.1038/s41563-018-0143-0
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41563-018-0143-0
- Springer Nature Limited